|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.660 CNY | -0.53% |
|
0.00% | -10.73% |
| 03-27 | RAAS Blood Products' 2025 Profit Slides 28%, Revenue Falls 10% | MT |
| 03-27 | Shanghai RAAS Blood Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Capitalization | 37.11B 5.44B 4.63B 4.25B 4.03B 7.43B 509B 7.59B 49.86B 19.62B 244B 20.41B 19.99B 867B | P/E ratio 2026 * |
20.2x | P/E ratio 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise value | 37.11B 5.44B 4.63B 4.25B 4.03B 7.43B 509B 7.59B 49.86B 19.62B 244B 20.41B 19.99B 867B | EV / Sales 2026 * |
4.85x | EV / Sales 2027 * | 4.5x |
| Free-Float |
69.51% | Yield 2026 * |
1.59% | Yield 2027 * | 1.77% |
| 1 day | -0.53% | ||
| Current month | -2.75% | ||
| 1 month | -5.98% | ||
| 3 months | -10.16% | ||
| 6 months | -15.40% | ||
| Current year | -10.73% |
| 1 week | 5.64 |  | 5.79 |
| 1 month | 5.61 | | 5.98 |
| Current year | 5.61 | | 6.57 |
| 1 year | 5.61 | | 7.26 |
| 3 years | 5.61 | | 8.68 |
| 5 years | 4.98 | | 8.68 |
| 10 years | 4.98 | | 23.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jun Xu
CEO | Chief Executive Officer | 62 | - |
Le Qi Chen
DFI | Director of Finance/CFO | 39 | 26/10/2021 |
Hong Qiu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Li Xia Tan
CHM | Chairman | 56 | 30/07/2024 |
Jun Xu
CHM | Chairman | 62 | - |
Wei Bing Hu
BRD | Director/Board Member | 62 | 21/05/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.96% | 0% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.53% | 0.00% | -17.25% | -10.87% | 5.44B | |
| -0.27% | -1.08% | +33.10% | -6.67% | 76.69B | |
| -1.46% | -8.36% | +73.68% | +177.15% | 55.29B | |
| -1.06% | +58.80% | +58.80% | +58.80% | 49.73B | |
| -5.70% | -7.35% | -45.39% | -57.55% | 47.08B | |
| +1.42% | +3.91% | +59.63% | -36.75% | 27.29B | |
| -0.66% | +2.63% | +115.80% | -61.50% | 21.51B | |
| -0.72% | -1.50% | +69.40% | +29.00% | 19.15B | |
| -0.63% | -0.68% | +54.18% | +55.12% | 15.53B | |
| -0.65% | -2.25% | +127.34% | +379.72% | 14.77B | |
| Average | -0.92% | -0.60% | +52.93% | +52.65% | 33.25B | |
| Weighted average by Cap. | -1.26% | -1.46% | +46.54% | +42.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.64B 1.12B 954M 875M 830M 1.53B 105B 1.56B 10.27B 4.04B 50.31B 4.2B 4.12B 179B | 8.25B 1.21B 1.03B 944M 895M 1.65B 113B 1.69B 11.08B 4.36B 54.3B 4.54B 4.44B 193B |
| Net income | 1.89B 277M 236M 216M 205M 378M 25.92B 387M 2.54B 999M 12.44B 1.04B 1.02B 44.18B | 2.08B 305M 259M 238M 226M 416M 28.52B 425M 2.79B 1.1B 13.68B 1.14B 1.12B 48.59B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/04/26 | 5.660 ¥ | -0.53% | 22,001,300 |
| 20/04/26 | 5.690 ¥ | -0.18% | 17,679,480 |
| 17/04/26 | 5.700 ¥ | -0.70% | 22,412,670 |
| 16/04/26 | 5.740 ¥ | +0.88% | 30,089,330 |
| 15/04/26 | 5.690 ¥ | +0.53% | 29,785,080 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 002252 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition